アメリカの片頭痛治療薬市場

QYResearchが発行した調査報告書(QYR70509581)
◆英語タイトル:United States Migraine Drugs Market Report 2017
◆商品コード:QYR70509581
◆発行会社(リサーチ会社):QYResearch
◆発行日:2017年5月8日
◆ページ数:113
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆産業分野:バイオ・医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,800 ⇒換算¥429,400見積依頼/購入/質問フォーム
EnterpriseUSD7,600 ⇒換算¥858,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、アメリカの片頭痛治療薬市場について調査・分析し、片頭痛治療薬のアメリカ市場概観、片頭痛治療薬の種類別市場分析、用途別市場分析、片頭痛治療薬のアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・片頭痛治療薬のアメリカ市場概観
・片頭痛治療薬の種類別市場規模
・片頭痛治療薬の用途別市場規模
・片頭痛治療薬のアメリカ市場規模
・片頭痛治療薬のアメリカ市場予測
・片頭痛治療薬の製造メーカー分析
・片頭痛治療薬のメーカー別生産量
・片頭痛治療薬のメーカー別市場シェア
・片頭痛治療薬の価格動向・価格分析
・片頭痛治療薬の販売(売上高)動向
・片頭痛治療薬の貿易(輸出・輸入)動向
・片頭痛治療薬の産業チェーン分析
・片頭痛治療薬のマーケティング戦略分析
・片頭痛治療薬の販売業者(代理店)リスト
・片頭痛治療薬の市場環境分析
...
【レポートの概要】

In this report, the United States Migraine Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Migraine Drugs in these regions, from 2012 to 2022 (forecast).

United States Migraine Drugs market competition by top manufacturers/players, with Migraine Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Allergan
Merck
Pfizer
Teva
Pfizer
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Sumatriptan
Zolmitriptan
Rizatriptan
Other Drug
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Migraine Drugs for each application, including
Hospitals
Clinics
Household Use
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

United States Migraine Drugs Market Report 2017
1 Migraine Drugs Overview
1.1 Product Overview and Scope of Migraine Drugs
1.2 Classification of Migraine Drugs by Product Category
1.2.1 United States Migraine Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Migraine Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Sumatriptan
1.2.4 Zolmitriptan
1.2.5 Rizatriptan
1.2.6 Other Drug
1.3 United States Migraine Drugs Market by Application/End Users
1.3.1 United States Migraine Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 United States Migraine Drugs Market by Region
1.4.1 United States Migraine Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Migraine Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Migraine Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Migraine Drugs Status and Prospect (2012-2022)
1.4.5 New England Migraine Drugs Status and Prospect (2012-2022)
1.4.6 The South Migraine Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Migraine Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Migraine Drugs (2012-2022)
1.5.1 United States Migraine Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Migraine Drugs Revenue and Growth Rate (2012-2022)

2 United States Migraine Drugs Market Competition by Players/Suppliers
2.1 United States Migraine Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Migraine Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Migraine Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Migraine Drugs Market Competitive Situation and Trends
2.4.1 United States Migraine Drugs Market Concentration Rate
2.4.2 United States Migraine Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Migraine Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Migraine Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Migraine Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Migraine Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Migraine Drugs Price by Region (2012-2017)

4 United States Migraine Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Migraine Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Migraine Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Migraine Drugs Price by Type (2012-2017)
4.4 United States Migraine Drugs Sales Growth Rate by Type (2012-2017)

5 United States Migraine Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Migraine Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Migraine Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Migraine Drugs Players/Suppliers Profiles and Sales Data
6.1 Allergan
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Migraine Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Allergan Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Migraine Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.2 Migraine Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Teva
6.4.2 Migraine Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Teva Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.2 Migraine Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
6.6.2 Migraine Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Endo International
6.7.2 Migraine Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Endo International Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
6.8.2 Migraine Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Impax
6.9.2 Migraine Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Impax Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Abbott
6.10.2 Migraine Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Abbott Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bayer
6.12 Eli Lilly
6.13 Ethypharm
6.14 Kowa Pharmaceuticals America
6.15 Winston Pharmaceuticals
6.16 AstraZeneca

7 Migraine Drugs Manufacturing Cost Analysis
7.1 Migraine Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Migraine Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Migraine Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Migraine Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Migraine Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Migraine Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Migraine Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Migraine Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Migraine Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Migraine Drugs
Figure United States Migraine Drugs Market Size (K MT) by Type (2012-2022)
Figure United States Migraine Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Sumatriptan Product Picture
Figure Zolmitriptan Product Picture
Figure Rizatriptan Product Picture
Figure Other Drug Product Picture
Figure United States Migraine Drugs Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Migraine Drugs by Application in 2016
Figure Hospitals Examples
Figure Clinics Examples
Figure Household Use Examples
Figure Others Examples
Figure United States Migraine Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Migraine Drugs Sales (K MT) and Growth Rate (2012-2022)
Figure United States Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Migraine Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Migraine Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Migraine Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Migraine Drugs Sales Share by Players/Suppliers
Figure 2017 United States Migraine Drugs Sales Share by Players/Suppliers
Figure United States Migraine Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Migraine Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Migraine Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Migraine Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Migraine Drugs Revenue Share by Players/Suppliers
Table United States Market Migraine Drugs Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Migraine Drugs Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Migraine Drugs Market Share of Top 3 Players/Suppliers
Figure United States Migraine Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Migraine Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Migraine Drugs Product Category
Table United States Migraine Drugs Sales (K MT) by Region (2012-2017)
Table United States Migraine Drugs Sales Share by Region (2012-2017)
Figure United States Migraine Drugs Sales Share by Region (2012-2017)
Figure United States Migraine Drugs Sales Market Share by Region in 2016
Table United States Migraine Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Migraine Drugs Revenue Share by Region (2012-2017)
Figure United States Migraine Drugs Revenue Market Share by Region (2012-2017)
Figure United States Migraine Drugs Revenue Market Share by Region in 2016
Table United States Migraine Drugs Price (USD/MT) by Region (2012-2017)
Table United States Migraine Drugs Sales (K MT) by Type (2012-2017)
Table United States Migraine Drugs Sales Share by Type (2012-2017)
Figure United States Migraine Drugs Sales Share by Type (2012-2017)
Figure United States Migraine Drugs Sales Market Share by Type in 2016
Table United States Migraine Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Migraine Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Migraine Drugs by Type (2012-2017)
Figure Revenue Market Share of Migraine Drugs by Type in 2016
Table United States Migraine Drugs Price (USD/MT) by Types (2012-2017)
Figure United States Migraine Drugs Sales Growth Rate by Type (2012-2017)
Table United States Migraine Drugs Sales (K MT) by Application (2012-2017)
Table United States Migraine Drugs Sales Market Share by Application (2012-2017)
Figure United States Migraine Drugs Sales Market Share by Application (2012-2017)
Figure United States Migraine Drugs Sales Market Share by Application in 2016
Table United States Migraine Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Migraine Drugs Sales Growth Rate by Application (2012-2017)
Table Allergan Basic Information List
Table Allergan Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Allergan Migraine Drugs Sales Growth Rate (2012-2017)
Figure Allergan Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Migraine Drugs Sales Growth Rate (2012-2017)
Figure Merck Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Merck Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Migraine Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Migraine Drugs Sales Growth Rate (2012-2017)
Figure Teva Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Teva Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Migraine Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Migraine Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Endo International Basic Information List
Table Endo International Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Endo International Migraine Drugs Sales Growth Rate (2012-2017)
Figure Endo International Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Endo International Migraine Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Migraine Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Migraine Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Impax Basic Information List
Table Impax Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Impax Migraine Drugs Sales Growth Rate (2012-2017)
Figure Impax Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Impax Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Migraine Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Abbott Migraine Drugs Sales Growth Rate (2012-2017)
Figure Abbott Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Eli Lilly Basic Information List
Table Ethypharm Basic Information List
Table Kowa Pharmaceuticals America Basic Information List
Table Winston Pharmaceuticals Basic Information List
Table AstraZeneca Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Migraine Drugs
Figure Manufacturing Process Analysis of Migraine Drugs
Figure Migraine Drugs Industrial Chain Analysis
Table Raw Materials Sources of Migraine Drugs Major Players/Suppliers in 2016
Table Major Buyers of Migraine Drugs
Table Distributors/Traders List
Figure United States Migraine Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Migraine Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Migraine Drugs Price (USD/MT) Trend Forecast (2017-2022)
Table United States Migraine Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Migraine Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Migraine Drugs Sales Volume (K MT) Forecast by Type in 2022
Table United States Migraine Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Migraine Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Migraine Drugs Sales Volume (K MT) Forecast by Application in 2022
Table United States Migraine Drugs Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Migraine Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Migraine Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Migraine Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アメリカの片頭痛治療薬市場(United States Migraine Drugs Market Report 2017)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆